| 2024-02-29 | -28.9% | legal | SEC EDGAR | CC 8-K: 2.02 and (SEC Filing) |
| 2024-02-29 | -28.9% | legal | SEC EDGAR | CC 8-K: 5.02 (SEC Filing) |
| 2023-06-02 | +26.9% | legal | SEC EDGAR | CC 8-K: 1.01, 8.01 (SEC Filing) |
| 2023-06-01 | +24.6% | legal | SEC EDGAR | CC 8-K: 8.01 and (SEC Filing) |
| 2025-08-13 | +21.0% | executive | Seeking Alpha | Chemours surges to five-month high after cooling fluid qualifies with Samsung SSDs |
| 2025-08-13 | +21.0% | executive | Stock Titan | Samsung's New Cooling Breakthrough: Chemours Fluid Cuts Data Center Energy Use by 40% - Stock Titan |
| 2026-02-19 | -19.9% | earnings | Seeking Alpha | Chemours non-GAAP EPS of $0.05 misses by $0.02, revenue of $1.33B in-line |
| 2026-02-19 | -19.9% | legal | SEC EDGAR | CC 8-K: 2.02 and (SEC Filing) |
| 2026-02-19 | -19.9% | earnings | Quiver Quantitative | Chemours Company (CC) Stock Falls on Q4 2025 Earnings - Quiver Quantitative |
| 2026-02-19 | -19.9% | news | PR Newswire | The Chemours Company Reports Fourth Quarter and Full Year 2025 Results - PR Newswire |
| 2026-02-19 | -19.9% | earnings | ChartMill | Chemours (NYSE:CC) Stock Plummets 11% After Q4 Earnings Miss Estimates - ChartMill |
| 2026-02-19 | -19.9% | earnings | Investing.com | Chemours Co earnings missed by $0.02, revenue fell short of estimates - Investing.com |
| 2026-02-19 | -19.9% | earnings | marketscreener.com | Earnings Flash (CC) Chemours Posts Q4 Adjusted EPS $0.05, vs. FactSet Est of $0.07 - marketscreener.com |
| 2022-05-02 | +16.6% | legal | SEC EDGAR | CC 8-K: 2.02, 8.01 (SEC Filing) |
| 2026-02-03 | +16.5% | news | simplywall.st | The Chemours Company (NYSE:CC) Shares Fly 27% But Investors Aren't Buying For Growth - simplywall.st |
| 2024-02-13 | -14.1% | legal | SEC EDGAR | CC 8-K: 8.01 and (SEC Filing) |
| 2022-02-10 | -13.0% | legal | SEC EDGAR | CC 8-K: 2.02 and (SEC Filing) |
| 2026-03-24 | +12.1% | news | simplywall.st | Should Chemours’ $700 Million Debt Refinance Require Action From Chemours (CC) Investors? - simplywall.st |
| 2024-08-01 | -11.8% | legal | SEC EDGAR | CC 8-K: 2.02 and (SEC Filing) |
| 2026-02-20 | -11.4% | news | Seeking Alpha | Chemours outlines $800M–$900M adjusted EBITDA target for 2026 with focus on cash flow and deleveraging |
| 2026-02-20 | -11.4% | earnings | Seeking Alpha | The Chemours Company (CC) Q4 2025 Earnings Call Transcript |
| 2026-02-20 | -11.4% | earnings | Seeking Alpha | Chemours slides 11% on Q4 weakness in advanced performance materials |
| 2026-02-20 | -11.4% | earnings | Seeking Alpha | The Chemours Company 2025 Q4 - Results - Earnings Call Presentation |
| 2026-02-20 | -11.4% | news | The Motley Fool | Why Chemours Plunged Today - The Motley Fool |
| 2026-02-20 | -11.4% | earnings | Seeking Alpha | Chemours slides 11% on Q4 weakness in advanced performance materials (CC:NYSE) - Seeking Alpha |
| 2026-02-20 | -11.4% | news | GuruFocus | Chemours (CC) Shares Drop Significantly by 19% - GuruFocus |
| 2026-02-20 | -11.4% | earnings | Investing.com | Earnings call transcript: Chemours misses Q4 2025 earnings expectations, stock drops - Investing.com |
| 2026-02-10 | +11.3% | news | Investing.com Australia | Chemours Co stock hits 52-week high at 18.47 USD By Investing.com - Investing.com Australia |
| 2024-11-04 | +10.6% | legal | SEC EDGAR | CC 8-K: 2.02 and (SEC Filing) |
| 2025-10-16 | -10.4% | legal | SEC EDGAR | CC 8-K: 1.01, 2.03and8.01 (SEC Filing) |
| 2026-02-06 | +9.7% | news | Seeking Alpha | Mid-cap stocks with lowest dividend growth grade |
| 2025-05-06 | -9.5% | legal | SEC EDGAR | CC 8-K: 2.02 and (SEC Filing) |
| 2025-05-06 | -9.5% | news | Seeking Alpha | Chemours: Dividend Cut May Signal A Bottom Is Near (NYSE:CC) - Seeking Alpha |
| 2025-12-15 | -9.3% | news | Sahm | What Chemours (CC)'s New Titanium Technologies President Means For Its Operations‑First Strategy - Sahm |
| 2025-12-14 | -8.9% | earnings | Yahoo Finance | Chemours Company (CC) Up More than 12% Since Q3, Here’s What Wall Street Thinks About the Stock - Yahoo Finance |
| 2025-08-04 | +8.8% | legal | SEC EDGAR | CC 8-K: 1.01, 8.01 (SEC Filing) |
| 2026-02-23 | +8.3% | analyst | Seeking Alpha | Chemours: No Rush To Buy The Dip Given Non-AI Pressures (Downgrade) |
| 2026-02-23 | +8.3% | analyst | Investing.com | Jefferies raises Chemours stock price target to $17 on Opteon lift - Investing.com |
| 2026-02-23 | +8.3% | news | Stock Titan | Chip industry group adds Chemours exec to North America board - Stock Titan |
| 2026-02-23 | +8.3% | earnings | TradingView | Chemours' Q4 Earnings Surpass Estimates, Revenues In Line - TradingView |
| 2026-02-23 | +8.3% | analyst | Seeking Alpha | Chemours: No Rush To Buy The Dip Given Non-AI Pressures (Downgrade) (NYSE:CC) - Seeking Alpha |
| 2025-10-13 | +8.2% | news | Sahm | Chemours (CC) Is Down 14.9% After Legal and Environmental Risks Intensify—Has the Bull Case Changed? - Sahm |
| 2026-03-26 | +7.5% | news | Stock Titan | Vanguard disaggregates holdings after Jan 12, 2026 realignment; reports 0 shares in Chemours (CC) - Stock Titan |
| 2026-03-26 | +7.5% | news | GuruFocus | The Chemours Co (CC) Trading 3.61% Higher on Mar 26 - GuruFocus |
| 2026-03-02 | -7.2% | news | Zacks | Chemours Upsizes and Prices $700 Million Senior Notes Offering |
| 2026-03-02 | -7.2% | executive | Simply Wall St. | Chemours Balances Securities Probe With Data Center Cooling Expansion |
| 2026-03-02 | -7.2% | news | TradingView | Chemours Upsizes and Prices $700 Million Senior Notes Offering - TradingView |
| 2026-03-02 | -7.2% | news | Finviz | Chemours Upsizes and Prices $700 Million Senior Notes Offering - Finviz |
| 2026-03-25 | +7.2% | news | FinancialContent | The Chemours Company (NYSE: CC): A Deep Dive into a Chemical Giant at a Crossroads - FinancialContent |
| 2021-11-04 | +7.2% | legal | SEC EDGAR | CC 8-K: 2.02 and (SEC Filing) |
| 2024-06-03 | -7.1% | legal | SEC EDGAR | CC 8-K: 8.01 and (SEC Filing) |
| 2025-11-07 | +6.9% | news | Seeking Alpha | Chemours anticipates double-digit Opteon growth and $5.7B–$5.8B sales in 2025 as TSS segment outpaces expectations |
| 2025-11-07 | +6.9% | earnings | Seeking Alpha | The Chemours Company (CC) Q3 2025 Earnings Call Transcript |
| 2025-11-07 | +6.9% | earnings | Seeking Alpha | The Chemours Company 2025 Q3 - Results - Earnings Call Presentation |
| 2025-11-07 | +6.9% | earnings | Investing.com | Earnings call transcript: Chemours Co Q3 2025 sees stock drop after EPS miss - Investing.com |
| 2026-02-22 | +6.8% | news | StocksToTrade | Chemours Faces Financial Challenges Amid Stock Drop - StocksToTrade |
| 2026-02-21 | +6.8% | earnings | TIKR.com | Chemours Stock Drops 16.5% After Q4 Results: Analysts See $16 Fair Value - TIKR.com |
| 2026-02-21 | +6.8% | earnings | StocksToTrade | Chemours Stock Plummets Following Weak Earnings Report and Guidance - StocksToTrade |
| 2026-03-16 | +6.8% | legal | ACCESS Newswire | Core Silver Intersects High-Grade Copper-Molybdenum Veins up to 7.31% Cu & 1.01% Mo Confirming Large Porphyry System at Laverdiere |
| 2025-01-07 | +6.7% | legal | SEC EDGAR | CC 8-K: 5.02 and (SEC Filing) |
| 2023-03-15 | -6.6% | legal | SEC EDGAR | CC 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-03-31 | -6.5% | legal | SEC EDGAR | CC 8-K: 8.01 and (SEC Filing) |
| 2023-09-26 | -6.2% | news | GuruFocus | Unveiling The Chemours Co (CC)'s Value: Is It Really Priced Righ - GuruFocus |
| 2021-08-18 | -5.9% | legal | SEC EDGAR | CC 8-K: 1.01, 2.03, 8.01 (SEC Filing) |
| 2026-04-09 | +5.5% | analyst | Seeking Alpha | Tronox downgraded at Truist as costs seen outweighing Iran war upside |
| 2026-04-09 | +5.5% | news | Stock Traders Daily | How Chemours Company (the) (CC) Affects Rotational Strategy Timing - Stock Traders Daily |
| 2024-03-27 | -4.9% | news | Seeking Alpha | Chemours finds material weaknesses after internal review (NYSE:CC) - Seeking Alpha |
| 2021-05-03 | +4.8% | legal | SEC EDGAR | CC 8-K: 2.02 and (SEC Filing) |
| 2025-11-06 | +4.8% | earnings | Seeking Alpha | Chemours Non-GAAP EPS of $0.20 misses by $0.04, revenue of $1.5B in-line |
| 2025-11-06 | +4.8% | legal | SEC EDGAR | CC 8-K: 2.02 and (SEC Filing) |
| 2025-11-06 | +4.8% | earnings | Yahoo Finance | Chemours (CC) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance |
| 2025-11-06 | +4.8% | news | Business Wire | The Chemours Company Reports Third Quarter 2025 Results - Business Wire |
| 2025-11-06 | +4.8% | earnings | ChartMill | Chemours (NYSE:CC) Q3 2025 Earnings Miss Estimates, Stock Falls on Weak Guidance - ChartMill |
| 2025-08-08 | -4.7% | earnings | Seeking Alpha | Chemours: Solid Q2 And Legal Progress Are Bullish (Rating Upgrade) |
| 2025-08-08 | -4.7% | earnings | Seeking Alpha | Chemours: Solid Q2 And Legal Progress Are Bullish (Rating Upgrade) - Seeking Alpha |
| 2021-10-26 | -4.7% | legal | SEC EDGAR | CC 8-K: 5.02 (SEC Filing) |
| 2023-11-29 | +4.7% | legal | SEC EDGAR | CC 8-K: 8.01 and (SEC Filing) |
| 2023-11-29 | +4.7% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2026-04-10 | +4.6% | news | GlobeNewswire | HPF Market Forecast by Type, Form, Application, End-Use Industry, and Region to 2030 - Daikin Industries, AGC, and Chemours Co. Lead the Industry, Growing by $2 Billion Through 2030 |
| 2026-04-10 | +4.6% | news | GuruFocus | A Look at The Chemours Co (CC) After 4.0% Gain -- GF Value $20.7 - GuruFocus |
| 2025-08-06 | -4.2% | earnings | Seeking Alpha | The Chemours Company 2025 Q2 - Results - Earnings Call Presentation |
| 2025-08-06 | -4.2% | earnings | Seeking Alpha | The Chemours Company (CC) Q2 2025 Earnings Call Transcript |
| 2025-08-06 | -4.2% | news | Seeking Alpha | Chemours declares $0.0875 dividend |
| 2025-10-29 | -4.2% | news | Seeking Alpha | Chemours declares $0.0875 dividend |
| 2025-10-29 | -4.2% | news | Business Wire | Chemours Announces Fourth Quarter Dividend - Business Wire |
| 2024-04-30 | -4.2% | legal | SEC EDGAR | CC 8-K: 2.02 and (SEC Filing) |
| 2021-10-08 | +3.9% | legal | SEC EDGAR | CC 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-10-31 | -3.9% | legal | SEC EDGAR | CC 8-K: 5.02 and (SEC Filing) |
| 2023-07-28 | -3.7% | legal | SEC EDGAR | CC 8-K: 2.02, 2.05, 2.06 (SEC Filing) |
| 2024-12-13 | -3.7% | legal | SEC EDGAR | CC 8-K: 1.01, 2.03, 7.01 (SEC Filing) |
| 2023-04-27 | +3.6% | legal | SEC EDGAR | CC 8-K: 2.02 and (SEC Filing) |
| 2024-02-16 | +3.4% | legal | SEC EDGAR | CC 8-K: 5.02 (SEC Filing) |
| 2024-02-16 | +3.4% | legal | SEC EDGAR | CC 8-K: 5.02 and (SEC Filing) |
| 2025-11-05 | -3.1% | earnings | Seeking Alpha | Chemours Q3 2025 Earnings Preview |
| 2026-04-01 | -3.0% | news | Stock Titan | Chemours (NYSE: CC) director awarded 1,305 deferred stock units as equity compensation - Stock Titan |
| 2022-02-09 | +3.0% | legal | SEC EDGAR | CC 8-K: 5.02 (SEC Filing) |
| 2025-03-21 | -3.0% | news | GuruFocus | The Chemours Co (CC) Trading Down 3.89% on Mar 22 - GuruFocus |
| 2025-08-29 | +3.0% | legal | SEC EDGAR | CC 8-K: 5.02 (SEC Filing) |
| 2026-03-10 | +3.0% | news | GuruFocus | The Chemours Co (CC) Shares Up 4.65% on Mar 10 - GuruFocus |
| 2024-07-25 | +2.9% | legal | SEC EDGAR | CC 8-K: 5.02 (SEC Filing) |
| 2025-09-03 | -2.9% | legal | SEC EDGAR | CC 8-K: 8.01 (SEC Filing) |
| 2023-05-18 | +2.9% | legal | SEC EDGAR | CC 8-K: 5.02 and (SEC Filing) |
| 2025-06-29 | -2.8% | news | simplywall.st | Chemours (NYSE:CC) Has No Shortage Of Debt - simplywall.st |
| 2026-04-21 | +2.7% | earnings | PR Newswire | Chemours Announces Dates for First Quarter 2026 Earnings Release and Webcast Conference Call |
| 2026-04-21 | +2.7% | earnings | Stock Titan | Chemours will post Q1 results May 5, then host a public webcast - Stock Titan |
| 2024-07-09 | +2.7% | analyst | Investopedia | Chemours Rises as UBS Upgrades Stock To 'Buy' - Investopedia |
| 2025-05-12 | +2.5% | news | Forbes | What's Happening With Chemours Stock? - Forbes |
| 2023-06-30 | +2.4% | legal | SEC EDGAR | CC 8-K: 1.01 and (SEC Filing) |
| 2026-02-17 | +2.4% | news | Seeking Alpha | Chemours declares $0.0875 dividend |
| 2026-02-17 | +2.4% | news | Financial Times | Chemours Announces First Quarter Dividend - Financial Times |
| 2025-07-21 | +2.4% | news | Quiver Quantitative | Lobbying Update: $760,000 of THE CHEMOURS COMPANY lobbying was just disclosed | CC Stock News - Quiver Quantitative |
| 2026-03-03 | -2.4% | news | Stock Titan | Chemours Co (CC) officer receives two large RSU stock grants - Stock Titan |
| 2026-03-03 | -2.4% | news | Stock Titan | Chemours (NYSE: CC) executive gets RSU grant, shares withheld for tax - Stock Titan |
| 2026-03-03 | -2.4% | news | Stock Titan | Chemours (NYSE: CC) SVP receives RSU grant, withholds shares for taxes - Stock Titan |
| 2026-03-03 | -2.4% | executive | Stock Titan | Chemours (NYSE: CC) CEO gets 169,538-share stock award and tax withholding - Stock Titan |
| 2026-03-03 | -2.4% | news | Stock Titan | Chemours (NYSE: CC) officer granted 28,488 shares, 2,789 withheld for taxes - Stock Titan |
| 2021-07-13 | -2.4% | legal | SEC EDGAR | CC 8-K: 8.01 and (SEC Filing) |
| 2024-06-05 | +2.3% | legal | SEC EDGAR | CC 8-K: 5.02 and (SEC Filing) |
| 2026-02-26 | +2.3% | news | PR Newswire | The Chemours Company Announces Upsizing and Pricing of Private Offering of $700,000,000 of 7.875% Senior Notes Due 2034 |
| 2026-02-26 | +2.3% | news | Seeking Alpha | Chemours prices upsized $700M 7.875% senior notes due 2034 |
| 2026-02-26 | +2.3% | expansion | Seeking Alpha | The Chemours Company launches $600M private offering |
| 2026-02-26 | +2.3% | legal | SEC EDGAR | CC 8-K: 8.01 and (SEC Filing) |
| 2026-02-26 | +2.3% | news | Stock Titan | Chemours raises $700M at 7.875% to refinance 2027, 2028 notes - Stock Titan |
| 2026-02-26 | +2.3% | M&A | Stock Titan | Chemours targets $600M notes deal to redeem 2027 and 2028 issues - Stock Titan |
| 2023-03-23 | -2.2% | legal | SEC EDGAR | CC 8-K: 5.02 and (SEC Filing) |
| 2025-02-11 | -2.2% | legal | SEC EDGAR | CC 8-K: 5.02, 8.01 (SEC Filing) |
| 2021-08-05 | +2.1% | legal | SEC EDGAR | CC 8-K: 8.01 and (SEC Filing) |
| 2026-04-14 | -2.1% | news | Seeking Alpha | Plastics prices climb as supply disruptions ripple through petrochemical markets |
| 2025-03-08 | -2.1% | news | Intellectia AI | CC Forecast — Price Prediction for 2026. Should I Buy CC? - Intellectia AI |
| 2025-10-28 | -2.0% | earnings | Seeking Alpha | Chemours: Getting In Before The Upside And Before Q3 |
| 2025-10-28 | -2.0% | earnings | Seeking Alpha | Chemours: Getting In Before The Upside And Before Q3 - Seeking Alpha |
| 2025-07-26 | -2.0% | news | simplywall.st | Is It Time To Consider Buying The Chemours Company (NYSE:CC)? - simplywall.st |
| 2021-07-29 | +2.0% | legal | SEC EDGAR | CC 8-K: 2.02 and (SEC Filing) |
| 2025-12-08 | -2.0% | earnings | Yahoo Finance | JPMorgan Reduces PT on The Chemours Company (CC) to $13 From $15, Keeps a Neutral Rating - Yahoo Finance |
| 2025-08-05 | -2.0% | earnings | Seeking Alpha | Chemours stock edges higher as company beats quarterly estimates |
| 2025-08-05 | -2.0% | legal | SEC EDGAR | CC 8-K: 2.02 and (SEC Filing) |
| 2025-08-05 | -2.0% | earnings | Seeking Alpha | Chemours: Refrigerants Make This Company A Buy Before Q2 2025 Report - Seeking Alpha |
| 2022-08-22 | +1.9% | legal | SEC EDGAR | CC 8-K: 5.02 and (SEC Filing) |
| 2025-07-17 | +1.8% | news | Quiver Quantitative | Lobbying Update: $90,000 of THE CHEMOURS COMPANY lobbying was just disclosed - Quiver Quantitative |
| 2025-12-22 | -1.8% | news | The Motley Fool | This Chemicals Stock Is Down 32% but Just Became a Top 5 Holding After One Fund's $13 Million Bet - The Motley Fool |
| 2022-07-23 | +1.8% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Chemours (CC) - Zacks Investment Research |
| 2023-05-25 | -1.7% | earnings | TradingView | Chemours Company (The) Earnings and Revenue – NYSE:CC - TradingView |
| 2025-03-07 | -1.7% | news | Yahoo Finance | Chemours Co. (CC): Among Stocks That Will Go to the Moon According to Reddit - Yahoo Finance |
| 2026-03-20 | -1.7% | news | GlobeNewswire | The Chemours Company Investigated by the Portnoy Law Firm - GlobeNewswire |
| 2026-02-24 | -1.6% | legal | TradingView | Chemours Co SEC 10-K Report - TradingView |
| 2026-02-24 | -1.6% | executive | Stock Titan | New tech packs 8 Nvidia AI chips in 1U, cutting cooling energy up to 90% - Stock Titan |
| 2024-11-29 | -1.6% | legal | SEC EDGAR | CC 8-K: 1.01, 2.03, 7.01 (SEC Filing) |
| 2023-06-06 | -1.6% | legal | SEC EDGAR | CC 8-K: 5.02 and (SEC Filing) |
| 2026-02-18 | -1.5% | earnings | Seeking Alpha | Chemours Q4 2025 Earnings Preview |
| 2023-10-26 | +1.5% | legal | SEC EDGAR | CC 8-K: 2.02 and (SEC Filing) |
| 2021-07-18 | -1.5% | earnings | Zacks Investment Research | What date does Chemours's (CC) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research |
| 2025-02-18 | +1.4% | legal | SEC EDGAR | CC 8-K: 5.02 (SEC Filing) |
| 2025-02-18 | +1.4% | legal | SEC EDGAR | CC 8-K: 2.02 and (SEC Filing) |
| 2026-02-28 | -1.4% | news | Insider Monkey | The Chemours Company (CC): A Bull Case Theory |
| 2026-02-28 | -1.4% | news | Yahoo Finance | The Chemours Company (CC): A Bull Case Theory - Yahoo Finance |
| 2026-02-28 | -1.4% | news | Finviz | The Chemours Company (CC): A Bull Case Theory - Finviz |
| 2026-04-13 | -1.4% | news | Simply Wall St. | Is Chemours (CC) Offering Long Term Value After A 105% One Year Rally |
| 2026-04-13 | -1.4% | news | Simply Wall St. | Do Reaffirmed Bullish Views On Chemours (CC) Outweigh Its Balance Sheet And Legacy Risks? |
| 2025-11-11 | -1.4% | earnings | Seeking Alpha | Chemours: Solid Momentum Despite One-Time Costs In Q3 |
| 2025-11-11 | -1.4% | earnings | Seeking Alpha | Chemours: Solid Momentum Despite One-Time Costs In Q3 (CC) - Seeking Alpha |
| 2021-07-26 | +1.3% | legal | SEC EDGAR | CC 8-K: 1.01, 8.01 (SEC Filing) |
| 2024-03-25 | -1.3% | legal | SEC EDGAR | CC 8-K: 5.02 and (SEC Filing) |
| 2022-07-28 | +1.3% | legal | SEC EDGAR | CC 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-11-27 | -1.1% | legal | SEC EDGAR | CC 8-K: 1.01, 2.03, 8.01 (SEC Filing) |
| 2026-03-11 | +1.1% | executive | Quiver Quantitative | Chemours Co ($CC) CEO 2025 Pay Revealed - Quiver Quantitative |
| 2023-11-22 | +1.1% | legal | SEC EDGAR | CC 8-K: 5.02 and (SEC Filing) |
| 2023-02-09 | -1.1% | legal | SEC EDGAR | CC 8-K: 2.02 and (SEC Filing) |
| 2025-05-26 | +1.0% | news | Investing.com | Chemours’s SWOT analysis: chemical firm faces challenges, opportunities - Investing.com |
| 2023-03-29 | -1.0% | legal | SEC EDGAR | CC 8-K: 8.01 and (SEC Filing) |
| 2023-08-23 | +0.9% | legal | SEC EDGAR | CC 8-K: 1.01, 2.03 (SEC Filing) |
| 2021-10-28 | -0.9% | legal | SEC EDGAR | CC 8-K: 5.02 and (SEC Filing) |
| 2025-09-26 | +0.9% | news | Yahoo Finance | Is It Too Late To Consider Buying The Chemours Company (NYSE:CC)? - Yahoo Finance |
| 2026-02-12 | -0.9% | earnings | Yahoo Finance | Analysts Estimate Chemours (CC) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance |
| 2026-02-12 | -0.9% | news | Stock Traders Daily | Precision Trading with Chemours Company (the) (CC) Risk Zones - Stock Traders Daily |
| 2025-05-08 | +0.9% | earnings | Yahoo Finance | The Chemours Co (CC) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance |
| 2022-12-27 | -0.9% | legal | SEC EDGAR | CC 8-K: 5.02 and (SEC Filing) |
| 2025-11-30 | +0.8% | news | The Motley Fool | This Fund Bought $63 Million of Chemours Stock Even as Shares Sit 80% Below 2017 Highs - The Motley Fool |
| 2024-07-06 | +0.8% | news | intelligentinvestor.com.au | Chemours Company (The) (NYSE:CC) - Shares, Dividends & News - intelligentinvestor.com.au |
| 2023-07-26 | -0.8% | legal | SEC EDGAR | CC 8-K: 8.01 and (SEC Filing) |
| 2023-08-01 | +0.7% | legal | SEC EDGAR | CC 8-K: 8.01 and (SEC Filing) |
| 2024-11-13 | +0.7% | legal | SEC EDGAR | CC 8-K: 8.01 (SEC Filing) |
| 2025-11-10 | -0.7% | analyst | Investing.com | Truist Securities lowers Chemours stock price target to $18 on demand challenges - Investing.com |
| 2026-02-14 | +0.6% | news | Stock Titan | CC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan |
| 2026-04-11 | +0.5% | legal | Stock Titan | CC SEC Filings - Chemours Co 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2025-06-18 | +0.5% | earnings | Stock Titan | Chemours Reveals Strong Q2 Outlook: 40% EBITDA Surge in Refrigerants Division Despite Operations Hurdles - Stock Titan |
| 2021-06-03 | -0.4% | legal | SEC EDGAR | CC 8-K: 5.02 and (SEC Filing) |
| 2025-11-08 | +0.4% | analyst | The Globe and Mail | Analysts Offer Insights on Materials Companies: Nutrien (NTR) and Chemours Company (CC) - The Globe and Mail |
| 2021-09-29 | +0.3% | legal | SEC EDGAR | CC 8-K: 5.02 (SEC Filing) |
| 2024-04-25 | +0.3% | legal | SEC EDGAR | CC 8-K: 5.02 and (SEC Filing) |
| 2024-06-13 | +0.3% | legal | SEC EDGAR | CC 8-K: 5.02 and (SEC Filing) |
| 2026-01-29 | -0.3% | news | Seeking Alpha | Chemours: Upside More Confirmed In 2026E |
| 2026-01-29 | -0.3% | news | Seeking Alpha | Chemours: Upside More Confirmed In 2026E - Seeking Alpha |
| 2024-03-28 | -0.3% | legal | SEC EDGAR | CC 8-K: 2.02 and (SEC Filing) |
| 2026-03-12 | +0.3% | legal | PR Newswire | The Chemours Company Announces Completion of Private Offering of $700,000,000 Aggregate Principal Amount of 7.875% Senior Unsecured Notes Due 2034 |
| 2026-03-12 | +0.3% | legal | SEC EDGAR | CC 8-K: 1.01, 2.03, 8.01 (SEC Filing) |
| 2026-03-12 | +0.3% | news | Stock Titan | Chemours' $700M notes fund 2027, 2028 note redemptions - Stock Titan |
| 2026-03-12 | +0.3% | legal | PR Newswire | The Chemours Company Announces Completion of Private Offering of $700,000,000 Aggregate Principal Amount of 7.875% Senior Unsecured Notes Due 2034 - PR Newswire |
| 2026-03-12 | +0.3% | news | PR Newswire | INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC - PR Newswire |
| 2022-12-22 | +0.3% | legal | SEC EDGAR | CC 8-K: 5.02 (SEC Filing) |
| 2026-04-05 | +0.2% | news | Seeking Alpha | Iran conflict sparks sudden boom for U.S. chemical makers |
| 2026-04-03 | +0.2% | news | Cổng thông tin điện tử tỉnh Lào Cai | CC Stock Analysis: Chemours Company (The) 21.55 steady, minor gain in chemicals - Cổng thông tin điện tử tỉnh Lào Cai |
| 2025-03-10 | +0.2% | legal | SEC EDGAR | CC 8-K: 5.02 (SEC Filing) |
| 2026-01-18 | -0.2% | earnings | AD HOC NEWS | The Chemours Company: Is This Beaten-Down Chemicals Stock Quietly Resetting for a Turnaround? - AD HOC NEWS |
| 2021-09-01 | +0.2% | legal | SEC EDGAR | CC 8-K: 5.02 (SEC Filing) |
| 2026-01-25 | -0.2% | news | AD HOC NEWS | Chemours Stock Under Pressure: Is CC Turning into a Deep-Value Contrarian Bet? - AD HOC NEWS |
| 2026-01-16 | +0.2% | news | Seeking Alpha | Chemours to sell former titanium dioxide site in Taiwan |
| 2026-01-16 | +0.2% | legal | SEC EDGAR | CC 8-K: 1.01, 7.01 (SEC Filing) |
| 2025-02-19 | +0.2% | earnings | Seeking Alpha | The Long-Term Upside For Chemours Company After Q4 2024 (NYSE:CC) - Seeking Alpha |
| 2022-10-25 | +0.2% | legal | SEC EDGAR | CC 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-03-16 | +0.2% | legal | SEC EDGAR | CC 8-K: 5.02 and (SEC Filing) |
| 2022-08-17 | -0.1% | analyst | TradingView | CC Forecast — Price Target — Prediction for 2027 - TradingView |
| 2025-08-14 | +0.0% | news | Yahoo Finance | Chemours (CC) Soars 18% as Firm Expected to Benefit From AI, Chip Boom - Yahoo Finance |
| 2021-05-22 | +0.0% | analyst | Benzinga | Chemours Analyst Ratings and Price Targets | NYSE:CC - Benzinga |
| 2021-12-01 | +0.0% | legal | SEC EDGAR | CC 8-K: 8.01 and (SEC Filing) |
| 2026-04-25 | — | news | GuruFocus | A Look at The Chemours Co (CC) After 10.0% Gain -- GF Value $20. - GuruFocus |
| 2026-04-24 | — | news | Stock Titan | BlackRock holds 14.3% of Chemours (NYSE: CC) — 21.48M shares reported - Stock Titan |